A recent study found that in CCL4-induced liver fibrosis mice, oral IPA intervention (20 mg/kg/d) aggravated liver damage and fibrosis by activating HSCs via the TGF-β1/Smad signaling pathway (Liu et al., 2021). The gene discussed is CCL4; the disease is Hepatic fibrosis.